Amneal Pharmaceuticals (AMRX) Capital Leases (2017 - 2026)
Amneal Pharmaceuticals' Capital Leases was $54.6 million in Q2 2026, down 2.5% from $56.02 million a year earlier and down 0.5% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Capital Leases (2017 - 2026) Analysis & Trends
At the end of FY2025, Capital Leases at Amneal Pharmaceuticals came in at $54.93 million, down 3.4% from FY2024.
- Capital Leases has now declined for three consecutive years, though with a five-year compound annual growth rate of 94.0% (FY2020 to FY2025).
- In earlier years, Capital Leases was $56.89 million in FY2024 (-2.9%), $58.57 million in FY2023 (-3.6%), $60.77 million in FY2022 (+0.9%) and $60.25 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Capital Leases since Q4 2020.
- Compared with a year earlier, Capital Leases has declined for 14 straight quarters, with an average decline of 3.2% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was Q4 2022 (growth of 0.9%); the worst was Q1 2025 (a decline of 3.7%).
- Per Business Quant data, AMRX's Capital Leases in the three quarters before Q2 2026 was $54.88 million (Q1 2026), $54.93 million (Q4 2025) and $55.67 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Amneal Pharmaceuticals | 6.34 Bn | 5.53 Bn | 334.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.60 Mn |
| Mar 31, 2026 | 54.88 Mn |
| Dec 31, 2025 | 54.93 Mn |
| Sep 30, 2025 | 55.67 Mn |
| Jun 30, 2025 | 56.02 Mn |
| Mar 31, 2025 | 56.60 Mn |
| Dec 31, 2024 | 56.89 Mn |
| Sep 30, 2024 | 57.56 Mn |
| Jun 30, 2024 | 58.01 Mn |
| Mar 31, 2024 | 58.81 Mn |
| Dec 31, 2023 | 58.57 Mn |
| Sep 30, 2023 | 59.35 Mn |
| Jun 30, 2023 | 59.84 Mn |
| Mar 31, 2023 | 60.24 Mn |
| Dec 31, 2022 | 60.77 Mn |
| Sep 30, 2022 | 61.31 Mn |
| Jun 30, 2022 | 60.01 Mn |
| Mar 31, 2022 | 60.29 Mn |
| Dec 31, 2021 | 60.25 Mn |
| Sep 30, 2021 | 60.97 Mn |
Amneal Pharmaceuticals Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();